Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 14 to 18, 2022. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 14 to 18, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Moderna Asks FDA to Approve Second Booster for All Adults
FRIDAY, March 18, 2022 (HealthDay News) — Moderna said late Thursday that it has asked the U.S. Food and Drug Administration to approve the emergency use of a second booster of its COVID-19 vaccine for all adults. In a statement, the company noted its request is based partly on recent data from the United States and Israel showing how well its vaccine protects against the omicron variant.
Sotrovimab May Prevent Progression to Severe COVID-19
FRIDAY, March 18, 2022 (HealthDay News) — For nonhospitalized patients with symptomatic mild-to-moderate COVID-19 and a high risk for progression, risk for all-cause hospitalization or death is reduced with sotrovimab versus placebo, according to a study published online March 14 in the Journal of the American Medical Association.
ACC Offers Guidance on Cardiovascular Sequelae of COVID-19
FRIDAY, March 18, 2022 (HealthDay News) — In a 2022 Expert Consensus Decision Pathway issued by the American College of Cardiology and published online March 16 in the Journal of the American College of Cardiology, guidance is provided for the evaluation and management of adults exhibiting cardiovascular sequelae of severe acute respiratory syndrome coronavirus 2 infection.
Ashish Jha Named New White House COVID-19 Coordinator
THURSDAY, March 17, 2022 (HealthDay News) — President Joe Biden announced Thursday that he has named Ashish Jha, M.D., the dean of the Brown University School of Public Health, to replace Jeff Zients as the country’s COVID-19 coordinator when Zients leaves his post next month.
COVID-19 Vaccines Do Not Impact IVF Success
THURSDAY, March 17, 2022 (HealthDay News) — Receipt of a COVID-19 mRNA vaccine does not affect the ovarian response or pregnancy rates in in vitro fertilization treatment, according to a study published online Feb. 25 in Fertility and Sterility.
Hospitalization of Infants, Children Aged 0 to 4 Up During Omicron
WEDNESDAY, March 16, 2022 (HealthDay News) — U.S. infants and children aged 0 to 4 years were hospitalized at a much higher rate during omicron variant predominance than during delta variant predominance, according to research published in the March 15 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Pfizer Asks FDA to Approve Second Booster for Seniors
WEDNESDAY, March 16, 2022 (HealthDay News) — Pfizer Inc. said Tuesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of a second COVID-19 booster shot for Americans 65 and older.
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy .jpg)
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy 
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
